- Home
- TRIB vs SOND Comparison
TRIB vs SOND Comparison
Compare TRIB & SOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- SOND
- Stock Information
- Founded
- TRIB 1992
- SOND 2014
- Country
- TRIB Ireland
- SOND United States
- Employees
- TRIB 380
- SOND N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SOND Hotels/Resorts
- Sector
- TRIB Health Care
- SOND Consumer Discretionary
- Exchange
- TRIB Nasdaq
- SOND Nasdaq
- Market Cap
- TRIB 10.7M
- SOND 30.3M
- IPO Year
- TRIB N/A
- SOND N/A
- Fundamental
- Price
- TRIB $0.71
- SOND $2.34
- Analyst Decision
- TRIB
- SOND
- Analyst Count
- TRIB 0
- SOND 0
- Target Price
- TRIB N/A
- SOND N/A
- AVG Volume (30 Days)
- TRIB 40.9K
- SOND 24.1K
- Earning Date
- TRIB 05-22-2025
- SOND 05-06-2025
- Dividend Yield
- TRIB N/A
- SOND N/A
- EPS Growth
- TRIB N/A
- SOND N/A
- EPS
- TRIB N/A
- SOND N/A
- Revenue
- TRIB $59,126,000.00
- SOND $624,458,000.00
- Revenue This Year
- TRIB $11.63
- SOND $28.50
- Revenue Next Year
- TRIB $10.13
- SOND $17.62
- P/E Ratio
- TRIB N/A
- SOND N/A
- Revenue Growth
- TRIB N/A
- SOND 8.32
- 52 Week Low
- TRIB $0.48
- SOND $0.88
- 52 Week High
- TRIB $3.55
- SOND $10.50
- Technical
- Relative Strength Index (RSI)
- TRIB 62.34
- SOND 51.45
- Support Level
- TRIB $0.51
- SOND $2.23
- Resistance Level
- TRIB $0.57
- SOND $2.49
- Average True Range (ATR)
- TRIB 0.06
- SOND 0.25
- MACD
- TRIB 0.02
- SOND 0.03
- Stochastic Oscillator
- TRIB 97.02
- SOND 48.36
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.